INSIGHTS ON DRUG DEVELOPMENT

  • High-Throughput 90-Minute ELISA
    9/17/2024

    Discover how one solution can be utilized to measure Human IgG and human IFN gamma, which are key targets in pharmacokinetic studies and immunotherapeutic drug safety testing, in just 90 minutes.

  • Evaluating Clone Performance And Cell-Specific Productivity
    8/6/2026

    See how continuous process monitoring and automated at-line analytics support confident CHO clone ranking, consistent cultivation, and scale-up by connecting pH, viable cell density, and more.

  • Using DSC And MDSC To Study Material Interactions Of APIs And Excipients
    1/7/2026

    Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.

  • Working With Clients To Develop Manufacturing Processes
    7/23/2026

    Greg Buenger, Group Leader of Chemical Development at Cambrex Charles City, on what it actually looks like when R&D hands a process to the plant — chemists on the floor for the first batch, advising operators and troubleshooting in real time.

  • AAV Downstream Challenges: Expert Insights
    5/22/2025

    Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.

DRUG DEVELOPMENT SOLUTIONS

  • Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.

  • Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.

  • Learn how to select the right media resins for your application based on various parameters such as particle size, molecular weight, fractionation ranges and pH.

  • OSDPredict™ uses artificial intelligence and machine learning to help sponsors proactively identify and address formulation challenges early — before they can disrupt downstream development.

  • Custom microscopy workstations to meet your advanced imaging needs.